<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
CMRX
Chimerix
$
()


  • Chimerix announces data highlighting clinical efficacy of ONC201 treatment

    8/16/2023 - 10:07am
  • Biotech Alert: Searches spiking for these stocks today

    8/3/2023 - 10:50am
  • Chimerix reports Q2 EPS (21c), consensus (24c)

    8/3/2023 - 07:01am
  • Chimerix CEO Mike Sherman to retire, Mike Andriole to succeed

    6/27/2023 - 16:11pm
  • Fly Intel: Pre-market Movers

    5/23/2023 - 09:12am
  • Chimerix initiated with an Outperform at Baird

    5/22/2023 - 16:06pm
  • Chimerix reports Q1 EPS (24c), consensus (25c)

    5/4/2023 - 07:03am
  • Hong Kong investigating new monkeypox case, SCMP reports

    5/1/2023 - 11:24am
  • Chimerix reports Q4 EPS (24c), consensus (24c)

    3/2/2023 - 07:08am
  • Chimerix announces launch of ONC201 phase 3 ACTION study

    12/8/2022 - 17:02pm
  • Chimerix issues statement regarding Rubric Capital Management press release

    11/11/2022 - 06:50am
  • Rubric Capital reports 8.51% stake in Chimerix, suggests liquidation

    11/10/2022 - 15:26pm
  • Chimerix reports Q3 EPS $2.75, consensus $2.14

    11/3/2022 - 07:15am
dynamic_feed Breaking News